Medline Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | -0.4% | +7.0% | |
| – | – | -6.1% | +29.1% | |
| – | – | -84.2% | +675.6% | |
| – | – | -84.2% | +675.6% | |
| – | – | +8.7% | +9.8% | |
| – | – | +16.9% | +7.0% | |
| – | – | +7.1% | +0.2% | |
| – | – | -1.5% | -4.6% | |
| – | – | +1.6% | -1.3% | |
| – | – | +14.5% | +2.0% | |
| – | – | +26.2% | -50.0% | |
| – | – | +24.9% | +10.6% | |
| – | – | – | – | |
| – | – | -2.7% | -35.0% | |
| – | – | – | – | |
| – | +0.0% | +0.0% | +3.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.